| Generalizable machine learning approach for COVID-19 mortality risk prediction using on-admission clinical and laboratory features SS Barough, SAA Safavi-Naini, F Siavoshi, A Tamimi, S Ilkhani, S Akbari, ... Scientific Reports 13 (1), 2399, 2023 | 13 | 2023 |
| Anti-inflammatory effects of grape seed extract in hemodialysis patients; a pilot study AH Alirezaei, AS Barough, T Azizi, SS Barough, A Ghorbanihaghjo, ... Journal of Renal Injury Prevention 6 (3), 184-187, 2016 | 12 | 2016 |
| Vascular endothelial growth factor as a predictive and prognostic biomarker for multiple sclerosis A Amini Harandi, F Siavoshi, S Shirzadeh Barough, A Amini Harandi, ... Neuroimmunomodulation 29 (4), 476-485, 2022 | 7 | 2022 |
| On-admission and dynamic trend of laboratory profiles as prognostic biomarkers in COVID-19 inpatients F Siavoshi, SAA Safavi-Naini, S Shirzadeh Barough, ... Scientific Reports 13 (1), 6993, 2023 | 5 | 2023 |
| A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue AA Harandi, H Pakdaman, A Medghalchi, N Kimia, A Kazemian, ... Scientific Reports 14 (1), 1343, 2024 | 2 | 2024 |
| A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study H Pakdaman, A Amini Harandi, K Gharagozli, F Siavoshi, ... Current Aging Science 16 (3), 234-239, 2023 | 1 | 2023 |
| Cerebral hemodynamic response to generalized anxiety disorder AA Harandi, N Kimia, A Medghalchi, E Sharifipour, H Pakdaman, ... Psychiatry Research: Neuroimaging 333, 111654, 2023 | | 2023 |
| Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial A Amini Harandi, H Pakdaman, F Karamiani, F Mohammadi, ... Neurological Sciences 44 (1), 393-396, 2023 | | 2023 |
